Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naresh Aggarwal

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Physical Review Letters|March 14, 2025
Room Temperature Superfluorescence from an Electron-Hole LiquidNaresh Aggarwal, Ajay Kumar Poonia, Dmitry N Dirin, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|December 23, 2011
Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girlsCourt Pedersen, Morten Breindahl, Naresh Aggarwal, et al.
Journal of the Pediatric Infectious Diseases Society|February 26, 2014
Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10-25 Years of AgeScott A Halperin, Yaela Baine, Joseph B Domachowske, et al.
The Journal of Infectious Diseases|October 14, 2017
Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or OlderTino F Schwarz, Naresh Aggarwal, Beate Moeckesch, et al.
Journal of the Pediatric Infectious Diseases Society|September 4, 2015
Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012-2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical TrialJoanne M Langley, Long Wang, Naresh Aggarwal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 29, 2026
Immunogenicity and Safety of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein-Based Vaccine When Co-administered With the Adjuvanted Recombinant Herpes Zoster Subunit Vaccine in Adults ≥ 50 Years of AgeJean-François Roussy, Patrick Dennis, Anil K Gupta, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 8, 2023
A pilot phase 2a, randomized, double-blind, placebo-controlled study to explore the antiviral activity, clinical outcomes, safety, and tolerability of rilematovir at two dose levels in non-hospitalized adults with respiratory syncytial virus infectionAnna C Nilsson, John Pullman, Piotr Napora, et al.
Nature Medicine|October 12, 2021
ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trialsRoberto A Calle, Neeta B Amin, Santos Carvajal-Gonzalez, et al.
The Journal of Infectious Diseases|July 13, 2013
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in childrenJoanne M Langley, Alfonso Carmona Martinez, Archana Chatterjee, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Physical Review Letters|March 14, 2025
Room Temperature Superfluorescence from an Electron-Hole LiquidNaresh Aggarwal, Ajay Kumar Poonia, Dmitry N Dirin, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|December 23, 2011
Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girlsCourt Pedersen, Morten Breindahl, Naresh Aggarwal, et al.
Journal of the Pediatric Infectious Diseases Society|February 26, 2014
Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10-25 Years of AgeScott A Halperin, Yaela Baine, Joseph B Domachowske, et al.
The Journal of Infectious Diseases|October 14, 2017
Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or OlderTino F Schwarz, Naresh Aggarwal, Beate Moeckesch, et al.
Journal of the Pediatric Infectious Diseases Society|September 4, 2015
Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012-2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical TrialJoanne M Langley, Long Wang, Naresh Aggarwal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 29, 2026
Immunogenicity and Safety of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein-Based Vaccine When Co-administered With the Adjuvanted Recombinant Herpes Zoster Subunit Vaccine in Adults ≥ 50 Years of AgeJean-François Roussy, Patrick Dennis, Anil K Gupta, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 8, 2023
A pilot phase 2a, randomized, double-blind, placebo-controlled study to explore the antiviral activity, clinical outcomes, safety, and tolerability of rilematovir at two dose levels in non-hospitalized adults with respiratory syncytial virus infectionAnna C Nilsson, John Pullman, Piotr Napora, et al.
Nature Medicine|October 12, 2021
ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trialsRoberto A Calle, Neeta B Amin, Santos Carvajal-Gonzalez, et al.
The Journal of Infectious Diseases|July 13, 2013
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in childrenJoanne M Langley, Alfonso Carmona Martinez, Archana Chatterjee, et al.
Pageof 2